Latest AI and machine learning research in leukemia for healthcare professionals.
Algorithmic decision support is rapidly becoming a staple of personalized medicine, particularly for high-stakes recommendations such as cancer subtyping in which access to patient-specific information can drastically alter the course of treatment, and thus, patient outcome. To enhance the utility of decision support systems, it is vital to provide not just recommendations, but also contextual inf...
The tumor microenvironment (TME) is a complex ecosystem of diverse cell types whose interactions govern tumor growth and clinical outcome. While multiple studies have extensively charted the TME's impact on immunotherapy, its role in chemotherapy response remains less explored. To address this, we developed DECODEM (DEcoupling Cell-type-specific Outcomes using DEconvolution and Machine learning), ...
PURPOSE: To develop and validate an AI method for automated quantification of whole-skeleton bone marrow (BM) metabolic activity using Carbon 11 (11C)...
Single-cell genomic technologies are transforming insect science, shifting the field from basic description to functional and mechanistic research. Th...
INTRODUCTION: Acute lymphoblastic leukemia (ALL) is a highly heterogeneous hematologic malignancy with poor prognosis in refractory and relapsed cases...
RESEARCH QUESTION: How are the scores obtained using the deep learning-based oocyte assessment system, MAGENTA, associated with outcomes of intracytop...
OBJECTIVE: Treatment decision-making for non-small cell lung cancer (NSCLC) is complex, necessitating individualized decision-support tools to improve...
BACKGROUND: International protocols for age estimation in subadults recommend combining different evidence according to tooth and bone maturity by rad...
OBJECTIVE: To develop and rigorously validate radiomics-based predictive models using postoperative intravoxel incoherent motion diffusion-weighted im...
Somatic evolution leads to clonal heterogeneity, which fuels cancer progression and therapy resistance. To decipher the consequences of clonal heterog...
Leukemia remains a prevalent hematologic malignancy, and its morphological heterogeneity presents challenges for reliable identification under optical...
Chronic kidney disease (CKD) is a prevalent global health issue, and nutritional management of CKD is an integral component through all stages of the ...
PURPOSE: The clinical significance of medullary abnormalities in the appendicular skeleton detected by computed tomography (CT) in patients with multi...
BACKGROUND AND AIMS: Cholangiocarcinoma (CCA) is one of the most lethal cancers, characterized by molecular heterogeneity and treatment resistance. To...
PURPOSE: Osteoporosis is an under-screened musculoskeletal disorder that results in diminished quality of life and significant burden to the healthcar...
Over the past 20 years, endothelial keratoplasty procedures have revolutionized the treatment of corneal endothelial disorders. These conditions have ...
PURPOSE: This study aims to evaluate the performance of artificial intelligence (AI)-assisted PET imaging in predicting neoadjuvant chemotherapy (NAC)...
BACKGROUND AND OBJECTIVES: We developed an automated morphological image recognition deep learning system (image recognition DLS) of peripheral blood ...
CONTEXT: Early detection of acute leukemia (AL) is crucial for timely intervention and improved outcomes. Machine learning (ML) models provide a promi...
OBJECTIVE: The aim of this study is to evaluate the prognostic performance of a nomogram integrating clinical parameters with deep learning radiomics ...